Kevin D. Bunker

Insider Reports History

Location
New York, NY
Signature
By: /s/ Melissa B. Epperly, Attorney-in-Fact for Kevin D. Bunker
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin D. Bunker:

Company Role Class Num Shares Value Price $ Report Date Ownership
Zentalis Pharmaceuticals, Inc. Chief Scientific Officer Common Stock 834,931 $8,591,106 $10.29 20 Dec 2023 Direct
Zentalis Pharmaceuticals, Inc. Chief Scientific Officer Common Stock 15,000 $154,344 $10.29 20 Dec 2023 Indirect
Zentalis Pharmaceuticals, Inc. Chief Scientific Officer Common Stock 350 $3,601 $10.29 20 Dec 2023 As UTMA custodian for sons

Insider Reports Filed by Kevin D. Bunker

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZNTL Zentalis Pharmaceuticals, Inc. 20 Dec 2023 1 $0 4 Chief Scientific Officer 21 Dec 2023, 17:47
ZNTL Zentalis Pharmaceuticals, Inc. 04 Oct 2023 2 -$118,355 4 Chief Scientific Officer 06 Oct 2023, 19:19
ZNTL Zentalis Pharmaceuticals, Inc. 26 May 2023 1 -$2,401,248 4 Chief Scientific Officer 31 May 2023, 21:09
ZNTL Zentalis Pharmaceuticals, Inc. 13 Feb 2023 2 -$207,629 4 Chief Scientific Officer 14 Feb 2023, 18:07
ZNTL Zentalis Pharmaceuticals, Inc. 01 Feb 2023 3 $0 4 Chief Scientific Officer 01 Feb 2023, 18:09
ZNTL Zentalis Pharmaceuticals, Inc. 03 Oct 2022 2 $0 4 Chief Scientific Officer 03 Oct 2022, 18:40
ZNTL Zentalis Pharmaceuticals, Inc. 10 Aug 2022 1 -$150,000 4 Chief Operating Officer 12 Aug 2022, 16:26
ZNTL Zentalis Pharmaceuticals, Inc. 20 Jul 2022 1 -$150,000 4 Chief Operating Officer 20 Jul 2022, 20:28
ZNTL Zentalis Pharmaceuticals, Inc. 13 Jul 2022 2 -$150,062 4 Chief Operating Officer 14 Jul 2022, 18:37
ZNTL Zentalis Pharmaceuticals, Inc. 05 Jul 2022 1 -$751,652 4 Chief Operating Officer 06 Jul 2022, 16:19
ZNTL Zentalis Pharmaceuticals, Inc. 11 Apr 2022 3 -$152,745 4 Chief Operating Officer 13 Apr 2022, 17:53
ZNTL Zentalis Pharmaceuticals, Inc. 21 Mar 2022 2 -$490,670 4 Chief Operating Officer 21 Mar 2022, 19:55
ZNTL Zentalis Pharmaceuticals, Inc. 10 Mar 2022 3 -$469,374 4 Chief Operating Officer 10 Mar 2022, 16:41
ZNTL Zentalis Pharmaceuticals, Inc. 22 Feb 2022 4 -$490,933 4 Chief Operating Officer 23 Feb 2022, 19:12
ZNTL Zentalis Pharmaceuticals, Inc. 10 Feb 2022 9 -$770,633 4 Chief Operating Officer 14 Feb 2022, 20:11
ZNTL Zentalis Pharmaceuticals, Inc. 20 Jan 2022 3 -$599,912 4 Chief Operating Officer 20 Jan 2022, 18:14
ZNTL Zentalis Pharmaceuticals, Inc. 10 Jan 2022 5 -$684,097 4 Chief Operating Officer 11 Jan 2022, 17:55
ZNTL Zentalis Pharmaceuticals, Inc. 20 Dec 2021 4 -$792,431 4 Chief Operating Officer 21 Dec 2021, 17:17
ZNTL Zentalis Pharmaceuticals, Inc. 10 Dec 2021 4 -$717,106 4 Chief Operating Officer 13 Dec 2021, 17:09
ZNTL Zentalis Pharmaceuticals, Inc. 22 Nov 2021 1 -$759,937 4 Chief Operating Officer 23 Nov 2021, 15:45
ZNTL Zentalis Pharmaceuticals, Inc. 10 Nov 2021 3 -$781,471 4 Chief Operating Officer 12 Nov 2021, 15:38
ZNTL Zentalis Pharmaceuticals, Inc. 01 Oct 2021 6 -$556,856 4 Chief Operating Officer 04 Oct 2021, 21:16
ZNTL Zentalis Pharmaceuticals, Inc. 01 Sep 2021 3 -$568,283 4 Chief Operating Officer 02 Sep 2021, 19:31
ZNTL Zentalis Pharmaceuticals, Inc. 02 Aug 2021 4 -$429,805 4 Chief Operating Officer 03 Aug 2021, 19:59
ZNTL Zentalis Pharmaceuticals, Inc. 06 Jul 2021 9 -$1,164,675 4 Chief Operating Officer 08 Jul 2021, 16:55
ZNTL Zentalis Pharmaceuticals, Inc. 01 Jul 2021 4 -$431,367 4 Chief Operating Officer 06 Jul 2021, 20:01
ZNTL Zentalis Pharmaceuticals, Inc. 01 Jun 2021 2 -$455,442 4 Chief Operating Officer 02 Jun 2021, 20:26